Data as of Oct 24
| +0.10 / +1.55%|
The 9 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 4.00. The median estimate represents a +83.49% increase from the last price of 6.54.
The current consensus among 9 polled investment analysts is to Buy stock in Solazyme Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.